FDA inspection
Hisun Pharmaceutical (Nantong) Co., Ltd.: FDA inspection ending Jul 12, 2024
FDA inspection 1245669 · Voluntary Action Indicated (VAI) · Nantong
Key facts
| Inspection ID | 1245669 |
|---|---|
| Firm | Hisun Pharmaceutical (Nantong) Co., Ltd. |
| FEI number | 3010956224 |
| Address | Rudong Coastal Economic, No 18 4th Haibin Road; Dev. Zone |
| City | Nantong |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Jul 12, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data